Product Images Topiramate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Topiramate NDC 70518-0625 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Topiramate 25mg 70518 0625 00
This is a description of a medication called Topiramate that comes in a 25mg tablet form with a quantity of 30. The medication is manufactured by Cipla USA, Inc. and the NDC number is 70518-0625-00. The directions for use are to be found in the package insert. It should be kept out of reach of children and stored at temperatures between 20-25°C (58-77°F) with some excursions permitted up to 15-30°C (59-86°F) [see USP]. It has been repackaged by RemedyRepack Inc., Indiana, PA 15701, 724.455.8762.*
Topiramate 25mg 70518 0625 01
This is a prescription-only medication named Topiramate, which comes in the form of 25mg tablets, and the package contains 30 tablets. The package mentions the NDC number, lot number, and source NDC. The package also offers directions for use and suggests that the medication be stored in a particular temperature range. The medication is repackaged by RemedyRepack Inc. located in Indiana, PA.*
Topiramate 25mg 70518 0625 02
This is a description for a medication called Topiramate. It is a 25mg tablet that requires a prescription to obtain. The stock keeping unit (SKU) is identified by the National Drug Code (NDC) number 70518-0625-02 with lot number and expiration date clearly indicated. The medication is manufactured by Cipla USA Inc. located in Miami, Florida. The medication should be kept out of the reach of children and stored within the temperature range of 20-25°C (58-77°F) with permissible excursions to 15-30°C (59-86°F). Directions for use are provided within the package insert. The medication may have been repackaged by RemedyRepack Inc. located in Indiana.*
ccb7a1e4 a3a1 4a0e 8eb0 8086f53e314b 01
ccb7a1e4 a3a1 4a0e 8eb0 8086f53e314b 02
The text is a chart showing the cumulative seizure rates over time for two different dosages (50 mg/day and 400 mg/day) of a medication called Topiamate.*
ccb7a1e4 a3a1 4a0e 8eb0 8086f53e314b 03
The text describes the change in the average monthly migraine period rate during a double-blind phase of a medication called Topamax. The medication comes in two dosages, 100 mg/day and 200 mg/day. The change in monthly migraine rate is shown to be +56, with statistical significance indicated by p-values less than 0.01.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.